Isabel Lastres‐Becker

5.4k citations

63 papers · 4.3k indexed · h-index 37

Cellular and Molecular Neuroscience top 0.5%
Pharmacology top 0.2%
Molecular Biology top 5%
Neurology top 1%
Neurology top 1%

Co-authors: Javier Fernández‐Ruíz Antonio Cuadrado J.A. Ramos Sebastian Kügler Georg Auburger Alberto Rábano Nadia G. Innamorato Ángel J. García‐Yagüe
Topics: Cannabis and Cannabinoid Research (23 papers)Genomics, phytochemicals, and oxidative stress (17 papers)Genetic Neurodegenerative Diseases (16 papers)
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Pharmacology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Spain Germany United States

In The Last Decade

Isabel Lastres‐Becker

61 papers receiving 4.3k citations

Peers

Countries citing papers authored by Isabel Lastres‐Becker

Since Specialization

Citations

This map shows the geographic impact of Isabel Lastres‐Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Lastres‐Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Lastres‐Becker more than expected).

Fields of papers citing papers by Isabel Lastres‐Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Lastres‐Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Lastres‐Becker. The network helps show where Isabel Lastres‐Becker may publish in the future.

Co-authorship network of co-authors of Isabel Lastres‐Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Lastres‐Becker. A scholar is included among the top collaborators of Isabel Lastres‐Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Lastres‐Becker. Isabel Lastres‐Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia 2024 ·Antioxidants ·(unknown),(unknown),(unknown),Carmen Rodríguez‐Cueto,Javier Fernández‐Ruíz,Eva de Lago,Isabel Lastres‐Becker	1
2	The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis 2023 ·Antioxidants ·(unknown),Chang Hoon Shin,(unknown),Myriam Gorospe,Isabel Lastres‐Becker	19
3	Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis 2022 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Geoffrey Wells,(unknown),Ángeles Martín‐Requero,(unknown),Ana Martı́nez,Giorgio Giorgi,Pilar López‐Alvarado,Isabel Lastres‐Becker,J. Carlos Menéndez	17
4	Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy 2021 ·International Journal of Molecular Sciences ·Isabel Lastres‐Becker,(unknown),Marina Arribas-Blázquez,Inés Maestro,(unknown),Patricia Boya,Sebastián Cerdán,Alberto García‐Redondo,Ana Martı́nez,Ángeles Martín‐Requero	22
5	Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration 2021 ·Acta Neuropathologica Communications ·Marcos Galán-Ganga,Carmen Rodríguez‐Cueto,(unknown),Félix Hernández,Jesús Ávila,María Posada-Ayala,José L. Lanciego,Enrique Luengo,Manuela G. López,Alberto Rábano,Javier Fernández‐Ruíz,Isabel Lastres‐Becker	28
6	α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks 2021 ·Molecular Neurobiology ·Ángel J. García‐Yagüe,Isabel Lastres‐Becker,Leonidas Stefanis,Demetrios K. Vassilatis,Antonio Cuadrado	15
7	NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling 2019 ·Scientific Reports ·(unknown),(unknown),Natalia Robledinos-Antón,Ruth Blanco-Rojo,(unknown),Isabel Lastres‐Becker,Antonio Cuadrado,Francesc R. García-Gonzalo	16
8	CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies 2019 ·Redox Biology ·(unknown),Ángel J. García‐Yagüe,Sebastian Kügler,Isabel Lastres‐Becker	54
9	New alternative splicing variants of the ATXN2 transcript 2019 ·SHILAP Revista de lepidopterología ·Isabel Lastres‐Becker,David Nonis,Joachim Nowock,Georg Auburger	12
10	Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease 2016 ·Antioxidants and Redox Signaling ·Isabel Lastres‐Becker,Ángel J. García‐Yagüe,Robert H. Scannevin,Marı́a José Casarejos,Sebastian Kügler,Alberto Rábano,Antonio Cuadrado	227
11	Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis 2013 ·Brain ·Isabel Lastres‐Becker,Nadia G. Innamorato,Tomasz Jaworski,Alberto Rábano,Sebastian Kügler,Fred Van Leuven,Antonio Cuadrado	131
12	Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: Modulation by the Nrf2/Trx axis 2010 ·Free Radical Biology and Medicine ·Mireia Niso‐Santano,Rosa A. González‐Polo,José Manuel Bravo‐San Pedro,Rubén Gómez‐Sánchez,Isabel Lastres‐Becker,Miguel A. Ortiz‐Ortiz,Germán Soler,José M. Morán,Antonio Cuadrado,José M. Fuentes	111
13	Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice 2008 ·Human Molecular Genetics ·Isabel Lastres‐Becker,Susanne Brodesser,Dieter Lütjohann,Mekhman Azizov,(unknown),Edith Hintermann,Konrad Sandhoff,Annette Schürmann,Joachim Nowock,Georg Auburger	104
14	Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease 2005 ·Neurobiology of Disease ·Isabel Lastres‐Becker,Francisco Molina‐Holgado,J.A. Ramos,Raphael Mechoulam,Javier Fernández‐Ruíz	323
15	Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence 2004 ·Brain Research ·Eva de Lago,Rosario de Miguel,Isabel Lastres‐Becker,J.A. Ramos,Javier Fernández‐Ruíz	78
16	Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo 2004 ·Neuroreport ·Isabel Lastres‐Becker,Nicolas Bizat,Frédéric Boyer,Philippe Hantraye,Javier Fernández‐Ruíz,Emmanuel Brouillet	48
17	Effects of cannabinoids in the rat model of Huntington’s disease generated by an intrastriatal injection of malonate 2003 ·Neuroreport ·Isabel Lastres‐Becker,Nicolas Bizat,Frédéric Boyer,Philippe Hantraye,Emmanuel Brouillet,Javier Fernández‐Ruíz	52
18	Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease 2002 ·Synapse ·Isabel Lastres‐Becker,Henrik H. Hansen,Fernando Berrendero,Rosario de Miguel,Alberto Pérez‐Rosado,Jorge Manzanares,J.A. Ramos,Javier Fernández‐Ruíz	95
19	Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease 2002 ·Neurotoxicity Research ·Isabel Lastres‐Becker,María Gómez‐Ruíz,Rosario de Miguel,J.A. Ramos,Javier Fernández‐Ruíz	22
20	Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration 2001 ·Journal of Neurochemistry ·Henrik H. Hansen,Patricia C. Schmid,Petra Bittigau,Isabel Lastres‐Becker,Fernando Berrendero,Jorge Manzanares,Chrysanthy Ikonomidou,Harald H.O. Schmid,Javier Fernández‐Ruíz,Harald S. Hansen	187

About Isabel Lastres‐Becker

Isabel Lastres‐Becker is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Pharmacology, having authored 63 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (23 papers), Genomics, phytochemicals, and oxidative stress (17 papers) and Genetic Neurodegenerative Diseases (16 papers). The work is most often cited by research in Biological Psychiatry (277 citations), Cellular and Molecular Neuroscience (2.0k citations) and Pharmacology (1.7k citations). Isabel Lastres‐Becker has collaborated with scholars based in Spain, Germany and United States. Frequent co-authors include Javier Fernández‐Ruíz, Antonio Cuadrado, J.A. Ramos, Sebastian Kügler, Georg Auburger, Alberto Rábano, Nadia G. Innamorato, Ángel J. García‐Yagüe, Raphael Mechoulam and Rosario de Miguel. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact